Geode Capital Management’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Sell |
|
|||||
|
2025
Q1 | $140K | Buy |
|
|||||
|
2024
Q4 | $105K | Sell |
|
|||||
|
2024
Q3 | $754K | Buy |
|
|||||
|
2024
Q2 | $853K | Buy |
|
|||||
|
2024
Q1 | $1.26M | Buy |
|
|||||
|
2023
Q4 | $191K | Buy |
|
|||||
|
2023
Q3 | $166K | Buy |
|
|||||
|
2023
Q2 | $91.4K | Sell |
|
|||||
|
2023
Q1 | $68K | Sell |
|
|||||
|
2022
Q4 | $82K | Buy |
|
|||||
|
2022
Q3 | $149K | Hold |
|
|||||
|
2022
Q2 | $179K | Buy |
|
|||||
|
2022
Q1 | $303K | Hold |
|
|||||
|
2021
Q4 | $293K | Hold |
|
|||||
|
2021
Q3 | $408K | Buy |
|
|||||
|
2021
Q2 | $472K | Buy |
|
|||||
|
2021
Q1 | $393K | Buy |
|
|||||
|
2020
Q4 | $275K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $44K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $33K | Hold |
|
|||||
|
2015
Q3 | $88K | Buy |
|